Effect of Oral Levamisole Supplementation to Hepatitis B Vaccination on the Rate of Immune Response in Chronic Hemodialysis Patients

Nephron ◽  
2000 ◽  
Vol 84 (3) ◽  
pp. 291-292 ◽  
Author(s):  
M. Deniz Ayli ◽  
Cüneyt Ensari ◽  
Meltem Ayli ◽  
Fahri Mandiroglu ◽  
Suat Mut
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Chronic Hemodialysis ◽  
Hepatitis B Vaccination

Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination

Vaccine ◽  
2011 ◽  
Vol 29 (12) ◽  
pp. 2242-2247 ◽  
Author(s):  
Theodoros Eleftheriadis ◽  
Vassilios Liakopoulos ◽  
Georgia Antoniadi ◽  
Ioannis Stefanidis ◽  
Grammati Galaktidou
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccination ◽  
Indoleamine 2,3 Dioxygenase

scholarly journals An investigation of the efficacy on hepatitis B vaccination in hemodialysis patients in Ardabil, Iran

2018 ◽  
Vol 8 (1) ◽  
pp. 6-10
Author(s):  
Susan Mohammadi Kebar ◽  
Saeed Hoseininia ◽  
Yousef Mohammadi Kebar ◽  
Mohammad Broumand
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Poor Response ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine ◽  
Hepatitis B Vaccination ◽  
Double Dose ◽  
Serological Markers ◽  
The Past ◽  
Lower Immune Response

Introduction: Hemodialysis patients usually demonstrate lower immune response to hepatitis B vaccine compared to non-uremic population. Objectives: The present study aimed to determine the level of response to hepatitis B vaccination in patients under hemodialysis. Patients and Methods: This study was conducted on 172 live patients receiving hemodialysis in the dialysis department of Buali hospital in Ardabil, Iran (2015). To analyze their response to the vaccine, their vaccination titers were investigated. Before vaccination, the serological markers of hepatitis B and C were checked in all of the patients. Those for whom HBsAg and HBsAb results were negative and had not received the vaccinein the past entered the study. The patients received a double dose of hepatitis B vaccine at 0, 1, and 6 months after the beginning of dialysis. The response to the vaccine was investigated by measuring the level of patients’ hepatitis B antibody one month after receiving the last dose of the vaccine. Results: Seventy patients (40% of the total) displayed a proper immune response to the vaccine, 34 patients (19.8%) were without, and 68 patients (39.5%) were identified to have poor response. The results of Pearson’s correlation test indicated that there is a negative correlation between the patients’ age and their response to the vaccine. Conclusion: The results of this study indicated that higher age is one of the factors that reduce the effectiveness of hepatitis B vaccine in hemodialysis patients.

Recombinant Hepatitis B Vaccine Use in Chronic Hemodialysis Patients

Nephron ◽  
1996 ◽  
Vol 72 (4) ◽  
pp. 536-543 ◽  
Author(s):  
F. Fabrizi ◽  
S. Di Filippo ◽  
D. Marcelli ◽  
I. Guarnori ◽  
L. Raffaele ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Hemodialysis Patients ◽  
Chronic Hemodialysis ◽  
Hepatitis B Vaccine ◽  
Recombinant Hepatitis
Sign in / Sign up

Export Citation Format

Share Document